Antihaemophilic globulin: preparation by an improved cryoprecipitation method and clinical use.
作者信息
Brown D L, Hardisty R M, Kosoy M H, Bracken C
出版信息
Br Med J. 1967 Apr 8;2(5544):79-85. doi: 10.1136/bmj.2.5544.79.
Abstract
摘要
相似文献
1
Antihaemophilic globulin: preparation by an improved cryoprecipitation method and clinical use.抗血友病球蛋白：用改良冷沉淀法制备及临床应用
Br Med J. 1967 Apr 8;2(5544):79-85. doi: 10.1136/bmj.2.5544.79.
2
Pre-assayed AHF concentrate therapy for hemophilia.
Bibl Haematol. 1968;29:1160-5. doi: 10.1159/000384756.
3
[New viewpoints in the treatment of hemophilia].[血友病治疗的新观点]
Dtsch Med Wochenschr. 1973 Sep 28;98(39):1814-6. doi: 10.1055/s-0028-1107135.
4
Cryoprecipitate therapy in haemophilia.
Scott Med J. 1969 Jan;14(1):1-9. doi: 10.1177/003693306901400101.
5
[Preparatory procedures for obtaining antihemolytic globulin (factor VIII) by the cryoprecipitation method and its various properties].
Pol Tyg Lek. 1969 Jun 2;24(22):826-9.
6
[Hemophilia A--complications and their treatment--illustrated by a case].
MMW Munch Med Wochenschr. 1976 Mar 5;118(10):291-2.
7
THE IN VIVO LONGEVITY OF ANTIHAEMOPHILIC FACTOR (FACTOR VIII).抗血友病因子（因子VIII）的体内寿命
Br J Haematol. 1964 Apr;10:225-37. doi: 10.1111/j.1365-2141.1964.tb00697.x.
8
[Hemophilic arthropathy of the knee joint. Treatment of hemorrhages of the knee-joint and their consequences].[膝关节血友病性关节病。膝关节出血的治疗及其后果]
Monatsschr Kinderheilkd (1902). 1970 Feb;118(2):29-41.
9
Therapy of hereditary disorders of blood coagulation.遗传性凝血障碍的治疗。
Mod Treat. 1968 Jan;5(1):39-60.
10
[Basic aspects of the conservative therapy of hemophilic joint diseases].
Ter Arkh. 1971 Mar;43(3):76-83.
引用本文的文献
1
Hip arthroplasty in a haemophiliac and subsequent prophylactic therapy with cryoprecipitate.血友病患者的髋关节置换术及随后的冷沉淀预防性治疗。
Br Med J. 1967 Dec 2;4(5578):531-2. doi: 10.1136/bmj.4.5578.531.
2
Cryoprecipitate and the plastic blood-bag system: provision of adequate replacement therapy for routine treatment of haemophilia.冷沉淀与塑料血袋系统：为血友病常规治疗提供充足的替代疗法。
Br Med J. 1967 Apr 8;2(5544):88-91. doi: 10.1136/bmj.2.5544.88.
3
Comparison of qucik and slow thaw methods of producing cryoprecipitate antihaemophilic factor from fresh and 24-hour-old blood.新鲜血液和保存24小时血液制备冷沉淀抗血友病因子的快速解冻法与慢速解冻法比较
J Clin Pathol. 1969 Jul;22(4):447-52. doi: 10.1136/jcp.22.4.447.
4
A biological standard for measurement of blood coagulation Factor VIII activity.一种用于测量凝血因子VIII活性的生物学标准品。
Bull World Health Organ. 1971;45(3):337-51.
5
Intracranial ventricular haemorrhage as a first presentation of haemophilia. A case of successful surgical management.颅内脑室出血作为血友病的首发表现。一例成功的外科治疗病例。
J Neurol Neurosurg Psychiatry. 1969 Oct;32(5):470-3. doi: 10.1136/jnnp.32.5.470.
6
Cryoprecipitate and the use of the plastic blood bag system in the management of haemophilia and other coagulation disorders.冷沉淀制剂及塑料血袋系统在血友病和其他凝血障碍治疗中的应用
Proc R Soc Med. 1968 Jun;61(6):595-8. doi: 10.1177/003591576806100623.
7
Studies on the procurement of blood coagulation factor VIII: effects of plasma freezing rate and storage conditions on cryoprecipitate quality.凝血因子 VIII 的采购研究：血浆冷冻速率和储存条件对冷沉淀质量的影响。
J Clin Pathol. 1985 Apr;38(4):433-7. doi: 10.1136/jcp.38.4.433.
本文引用的文献
1
FURTHER EXPERIENCE IN USE OF HUMAN ANTIHAEMOPHILIC GLOBULIN (H.A.H.G.) FOR THE CONTROL OF BLEEDING AFTER DENTAL EXTRACTION IN HAEMOPHILIC PATIENTS: A REPORT TO THE MEDICAL RESEARCH COUNCIL'S WORKING PARTY ON HUMAN ANTIHAEOMOPHILIC GLOBULIN.
Lancet. 1965 May 8;1(7393):969-74. doi: 10.1016/s0140-6736(65)91213-4.
2
HIGH-POTENCY ANTIHAEMOPHILIC FACTOR CONCENTRATE PREPARED FROM CRYOGLOBULIN PRECIPITATE.由冷球蛋白沉淀制备的高活性抗血友病因子浓缩物。
Nature. 1964 Jul 18;203:312. doi: 10.1038/203312a0.
3
THE IN VIVO LONGEVITY OF ANTIHAEMOPHILIC FACTOR (FACTOR VIII).抗血友病因子（因子VIII）的体内寿命
Br J Haematol. 1964 Apr;10:225-37. doi: 10.1111/j.1365-2141.1964.tb00697.x.
4
THE FATE OF PROTHROMBIN AND FACTORS VIII, IX AND X TRANSFUSED TO PATIENTS DEFICIENT IN THESE FACTORS.凝血酶原以及凝血因子VIII、IX和X输注给缺乏这些因子的患者后的转归
Br J Haematol. 1963 Oct;9:532-47. doi: 10.1111/j.1365-2141.1963.tb05478.x.
5
The survival of factor VIII (antihemophilic globulin) and factor IX (plasma thromboplastin component) in normal humans.正常人中凝血因子VIII（抗血友病球蛋白）和凝血因子IX（血浆凝血活酶成分）的存活情况。
J Clin Invest. 1963 Jul;42(7):1040-7. doi: 10.1172/JCI104789.
6
A one-stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma.一期因子VIII（抗血友病球蛋白）测定及其在静脉血浆和毛细血管血浆中的应用。
Thromb Diath Haemorrh. 1962 May 15;7:215-28.
7
The determination of plasma fibrinogen by the clot-weight method.用凝块重量法测定血浆纤维蛋白原。
Biochem J. 1952 Aug;51(5):583-5. doi: 10.1042/bj0510583.
8
The treatment of classical hemophilia with cryoprecipitates. Laboratory control with readily available tests.
JAMA. 1966 Oct 17;198(3):243-7.
9
Production of high-potency concentrates of antihemophilic globulin in a closed-bag system.在密闭袋系统中生产高效抗血友病球蛋白浓缩物。
N Engl J Med. 1965 Dec 30;273(27):1443-7. doi: 10.1056/NEJM196512302732701.
Zotero 插件